Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cerus Corporation is a leading US biotechnology company dedicated to global blood safety. The company develops and markets the innovative INTERCEPT Blood System for pathogen inactivation of blood products for transfusions. This system enhances patient safety and significantly reduces the risk of transfusion-transmitted infections, representing a critical advance in healthcare medical technology.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cerus is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Cerus last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at -0.01 USD.
Across its last 3 earnings reports, Cerus stock moved by ±17.5% on average the following day. The largest reaction was +34% on 04/30/2026; 1 of 3 reactions were positive.
Cerus has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.